{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:08:51Z","timestamp":1793858931669,"version":"4.6.1"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SPP2395"],"award-info":[{"award-number":["SPP2395"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"crossref","award":["SPP2395"],"award-info":[{"award-number":["SPP2395"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004871","name":"Technische Universit\u00e4t Braunschweig","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004871","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Despite advances in antimicrobial and anti-inflammatory treatment, inflammation and its consequences remain a major challenge in the field of medicine. Inflammatory reactions can lead to life-threatening conditions such as septic shock, while chronic inflammation has the potential to worsen the condition of body tissues and ultimately lead to significant impairment of their functionality. Although the central nervous system has long been considered immune privileged to peripheral immune responses, recent research has shown that strong immune responses in the periphery also affect the brain, leading to reactive microglia, which belong to the innate immune system and reside in the brain, and neuroinflammation. The inflammatory response is primarily a protective mechanism to defend against pathogens and tissue damage. However, excessive and chronic inflammation can have negative effects on neuronal structure and function. Neuroinflammation underlies the pathogenesis of many neurological and neurodegenerative diseases and can accelerate their progression. Consequently, targeting inflammatory signaling pathways offers potential therapeutic strategies for various neuropathological conditions, particularly Parkinson\u2019s and Alzheimer\u2019s disease, by curbing inflammation. Here the blood\u2013brain barrier is a major hurdle for potential therapeutic strategies, therefore it would be highly advantageous to foster and utilize brain innate anti-inflammatory mechanisms. The tricarboxylic acid cycle-derived metabolite itaconate is highly upregulated in activated macrophages and has been shown to act as an immunomodulator with anti-inflammatory and antimicrobial functions. Mesaconate, an isomer of itaconate, similarly reduces the inflammatory response in macrophages. Nevertheless, most studies have focused on its esterified forms and its peripheral effects, while its influence on the CNS remained largely unexplored. Therefore, this study investigated the immunomodulatory and therapeutic potential of endogenously synthesized itaconate and its isomer mesaconate in lipopolysaccharide (LPS)-induced neuroinflammatory processes. Our results show that both itaconate and mesaconate reduce LPS-induced neuroinflammation, as evidenced by lower levels of inflammatory mediators, reduced microglial reactivity and a rescue of synaptic plasticity, the cellular correlate of learning and memory processes in the brain. Overall, this study emphasizes that both itaconate and mesaconate have therapeutic potential for neuroinflammatory processes in the brain and are of remarkable importance due to their endogenous origin and production, which usually leads to high tolerance.<\/jats:p>","DOI":"10.1186\/s12974-024-03188-3","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:02:47Z","timestamp":1724162567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The potential therapeutic role of itaconate and mesaconate on the detrimental effects of LPS-induced neuroinflammation in the brain"],"prefix":"10.1186","volume":"21","author":[{"given":"Melanie","family":"Ohm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Lonnemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Korte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,20]]},"reference":[{"key":"3188_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","volume":"213","author":"MJ Carson","year":"2006","unstructured":"Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev. 2006;213:48\u201365.","journal-title":"Immunol Rev"},{"issue":"2","key":"3188_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7(2):161\u20137.","journal-title":"Nat Rev Immunol"},{"key":"3188_CR3","doi-asserted-by":"publisher","first-page":"271359","DOI":"10.1155\/2013\/271359","volume":"2013","author":"S Biesmans","year":"2013","unstructured":"Biesmans S, Meert TF, Bouwknecht JA, Acton PD, Davoodi N, De Haes P, et al. Systemic immune activation leads to neuroinflammation and sickness behavior in mice. Med Inflamm. 2013;2013:271359.","journal-title":"Med Inflamm"},{"issue":"2","key":"3188_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2174\/1570159X14666151204122017","volume":"14","author":"MN Catorce","year":"2016","unstructured":"Catorce MN, Gevorkian G. LPS-induced murine neuroinflammation model: main features and suitability for pre-clinical assessment of nutraceuticals. Curr Neuropharmacol. 2016;14(2):155\u201364.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"3188_CR5","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Bi W, Xiao S, Lan X, Cheng X, Zhang J, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Sci Rep. 2019;9(1):5790.","journal-title":"Sci Rep"},{"issue":"28","key":"3188_CR6","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1523\/JNEUROSCI.0200-20.2020","volume":"40","author":"MMS Beyer","year":"2020","unstructured":"Beyer MMS, Lonnemann N, Remus A, Latz E, Heneka MT, Korte M. Enduring changes in neuronal function upon systemic inflammation are NLRP3 inflammasome dependent. J Neurosci. 2020;40(28):5480\u201394.","journal-title":"J Neurosci"},{"key":"3188_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.75889","author":"N Lonnemann","year":"2022","unstructured":"Lonnemann N, Hosseini S, Ohm M, Geffers R, Hiller K, Dinarello CA, et al. IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer\u2019s disease mouse model. Elife. 2022. https:\/\/doi.org\/10.7554\/eLife.75889.","journal-title":"Elife"},{"key":"3188_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175481","author":"A Skrzypczak-Wiercioch","year":"2022","unstructured":"Skrzypczak-Wiercioch A, Salat K. Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27175481.","journal-title":"Molecules"},{"key":"3188_CR9","doi-asserted-by":"publisher","first-page":"108116","DOI":"10.1016\/j.intimp.2021.108116","volume":"100","author":"L Wang","year":"2021","unstructured":"Wang L, Lin F, Ren M, Liu X, Xie W, Zhang A, et al. The PICK1\/TLR4 complex on microglia is involved in the regulation of LPS-induced sepsis-associated encephalopathy. Int Immunopharmacol. 2021;100:108116.","journal-title":"Int Immunopharmacol"},{"key":"3188_CR10","doi-asserted-by":"publisher","first-page":"100060","DOI":"10.1016\/j.bbih.2020.100060","volume":"4","author":"I Deng","year":"2020","unstructured":"Deng I, Corrigan F, Zhai G, Zhou XF, Bobrovskaya L. Lipopolysaccharide animal models of Parkinson\u2019s disease: recent progress and relevance to clinical disease. Brain Behav Immun Health. 2020;4:100060.","journal-title":"Brain Behav Immun Health"},{"issue":"7638","key":"3188_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481\u20137.","journal-title":"Nature"},{"issue":"2","key":"3188_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/1073858413504466","volume":"20","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV. Multiple roles for astrocytes as effectors of cytokines and inflammatory mediators. Neuroscientist. 2014;20(2):160\u201372.","journal-title":"Neuroscientist"},{"issue":"9","key":"3188_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2016.06.006","volume":"37","author":"E Colombo","year":"2016","unstructured":"Colombo E, Farina C. Astrocytes: key regulators of neuroinflammation. Trends Immunol. 2016;37(9):608\u201320.","journal-title":"Trends Immunol"},{"key":"3188_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnint.2013.00061","volume":"7","author":"HB Stolp","year":"2013","unstructured":"Stolp HB, Liddelow SA, Sa-Pereira I, Dziegielewska KM, Saunders NR. Immune responses at brain barriers and implications for brain development and neurological function in later life. Front Integr Neurosci. 2013;7:61.","journal-title":"Front Integr Neurosci"},{"issue":"1","key":"3188_CR15","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj D, Thangavel R, Natteru PA, Selvakumar GP, Saeed D, Zahoor H, et al. Neuroinflammation induces neurodegeneration. J Neurol Neurosurg Spine. 2016;1(1):1003.","journal-title":"J Neurol Neurosurg Spine."},{"key":"3188_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103194","author":"A Rauf","year":"2022","unstructured":"Rauf A, Badoni H, Abu-Izneid T, Olatunde A, Rahman MM, Painuli S, et al. Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27103194.","journal-title":"Molecules"},{"issue":"4","key":"3188_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3188_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1365-2990.2012.01307.x","volume":"39","author":"C Holmes","year":"2013","unstructured":"Holmes C. Review: systemic inflammation and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 2013;39(1):51\u201368.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"3188_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s42255-022-00565-1","volume":"4","author":"W He","year":"2022","unstructured":"He W, Henne A, Lauterbach M, Geissmar E, Nikolka F, Kho C, et al. Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages. Nat Metab. 2022;4(5):524\u201333.","journal-title":"Nat Metab"},{"key":"3188_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148548","author":"CG Peace","year":"2022","unstructured":"Peace CG, O\u2019Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI148548.","journal-title":"J Clin Invest"},{"issue":"7699","key":"3188_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556(7699):113\u20137.","journal-title":"Nature"},{"issue":"19","key":"3188_CR22","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci USA. 2013;110(19):7820\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3188_CR23","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1096\/fj.15-279398","volume":"30","author":"B Nemeth","year":"2016","unstructured":"Nemeth B, Doczi J, Csete D, Kacso G, Ravasz D, Adams D, et al. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. FASEB J. 2016;30(1):286\u2013300.","journal-title":"FASEB J"},{"issue":"1","key":"3188_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24(1):158\u201366.","journal-title":"Cell Metab"},{"issue":"7","key":"3188_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s42255-020-0210-0","volume":"2","author":"A Swain","year":"2020","unstructured":"Swain A, Bambouskova M, Kim H, Andhey PS, Duncan D, Auclair K, et al. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020;2(7):594\u2013602.","journal-title":"Nat Metab"},{"key":"3188_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12091255","author":"G Sun","year":"2022","unstructured":"Sun G, Zhang R, Liu C, Meng W, Pang Q. Itaconate attenuates neuroinflammation and exerts dopamine neuroprotection in Parkinson\u2019s disease through inhibiting NLRP3 inflammasome. Brain Sci. 2022. https:\/\/doi.org\/10.3390\/brainsci12091255.","journal-title":"Brain Sci"},{"key":"3188_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmet.2019.11.019","volume":"32","author":"T Cordes","year":"2020","unstructured":"Cordes T, Lucas A, Divakaruni AS, Murphy AN, Cabrales P, Metallo CM. Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab. 2020;32:122\u201335.","journal-title":"Mol Metab"},{"key":"3188_CR28","doi-asserted-by":"publisher","first-page":"1142639","DOI":"10.3389\/fphar.2023.1142639","volume":"14","author":"L Demuth","year":"2023","unstructured":"Demuth L, Ohm M, Michaelsen-Preusse K, Schulze K, Riese P, Guzman CA, et al. Influenza vaccine is able to prevent neuroinflammation triggered by H7N7 IAV infection. Front Pharmacol. 2023;14:1142639.","journal-title":"Front Pharmacol"},{"issue":"12","key":"3188_CR29","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1523\/JNEUROSCI.1740-17.2018","volume":"38","author":"S Hosseini","year":"2018","unstructured":"Hosseini S, Wilk E, Michaelsen-Preusse K, Gerhauser I, Baumgartner W, Geffers R, et al. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function. J Neurosci. 2018;38(12):3060\u201380.","journal-title":"J Neurosci"},{"key":"3188_CR30","doi-asserted-by":"publisher","first-page":"643650","DOI":"10.3389\/fncel.2021.643650","volume":"15","author":"S Hosseini","year":"2021","unstructured":"Hosseini S, Michaelsen-Preusse K, Schughart K, Korte M. Long-term consequence of non-neurotropic H3N2 influenza A virus infection for the progression of Alzheimer\u2019s disease symptoms. Front Cell Neurosci. 2021;15:643650.","journal-title":"Front Cell Neurosci"},{"issue":"50","key":"3188_CR31","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann N, Hosseini S, Marchetti C, Skouras DB, Stefanoni D, D\u2019Alessandro A, et al. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proc Natl Acad Sci USA. 2020;117(50):32145\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3188_CR32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mex.2014.07.002","volume":"1","author":"SC Sapcariu","year":"2014","unstructured":"Sapcariu SC, Kanashova T, Weindl D, Ghelfi J, Dittmar G, Hiller K. Simultaneous extraction of proteins and metabolites from cells in culture. MethodsX. 2014;1:74\u201380.","journal-title":"MethodsX"},{"issue":"8","key":"3188_CR33","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1074\/jbc.M115.676817","volume":"291","author":"J Meiser","year":"2016","unstructured":"Meiser J, Kramer L, Sapcariu SC, Battello N, Ghelfi J, D\u2019Herouel AF, et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J Biol Chem. 2016;291(8):3932\u201346.","journal-title":"J Biol Chem"},{"key":"3188_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12111058","author":"TH More","year":"2022","unstructured":"More TH, Mozafari B, Martens A, Herr C, Lepper PM, Danziger G, et al. Plasma metabolome alterations discriminate between COVID-19 and non-COVID-19 pneumonia. Metabolites. 2022. https:\/\/doi.org\/10.3390\/metabo12111058.","journal-title":"Metabolites"},{"issue":"3","key":"3188_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/cpmo.15","volume":"6","author":"C Jager","year":"2016","unstructured":"Jager C, Hiller K, Buttini M. Metabolic profiling and quantification of neurotransmitters in mouse brain by gas chromatography-mass spectrometry. Curr Protoc Mouse Biol. 2016;6(3):333\u201342.","journal-title":"Curr Protoc Mouse Biol"},{"issue":"9","key":"3188_CR36","doi-asserted-by":"publisher","first-page":"3429","DOI":"10.1021\/ac802689c","volume":"81","author":"K Hiller","year":"2009","unstructured":"Hiller K, Hangebrauk J, Jager C, Spura J, Schreiber K, Schomburg D. MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC\/MS based metabolome analysis. Anal Chem. 2009;81(9):3429\u201339.","journal-title":"Anal Chem"},{"issue":"7701","key":"3188_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-018-0023-4","volume":"556","author":"AC Wendeln","year":"2018","unstructured":"Wendeln AC, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556(7701):332\u20138.","journal-title":"Nature"},{"key":"3188_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:363.","journal-title":"Front Cell Neurosci"},{"issue":"5726","key":"3188_CR39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"issue":"2","key":"3188_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev. 2011;91(2):461\u2013553.","journal-title":"Physiol Rev"},{"issue":"6","key":"3188_CR41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/glia.22479","volume":"61","author":"L Qin","year":"2013","unstructured":"Qin L, Liu Y, Hong JS, Crews FT. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia. 2013;61(6):855\u201368.","journal-title":"Glia"},{"issue":"2","key":"3188_CR42","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/glia.22930","volume":"64","author":"DM Norden","year":"2016","unstructured":"Norden DM, Trojanowski PJ, Villanueva E, Navarro E, Godbout JP. Sequential activation of microglia and astrocyte cytokine expression precedes increased Iba-1 or GFAP immunoreactivity following systemic immune challenge. Glia. 2016;64(2):300\u201316.","journal-title":"Glia"},{"issue":"1","key":"3188_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2016.116","volume":"97","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68\/macrosialin: not just a histochemical marker. Lab Invest. 2017;97(1):4\u201313.","journal-title":"Lab Invest"},{"issue":"4","key":"3188_CR44","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","volume":"94","author":"M Pekny","year":"2014","unstructured":"Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94(4):1077\u201398.","journal-title":"Physiol Rev"},{"issue":"2","key":"3188_CR45","doi-asserted-by":"publisher","first-page":"a020420","DOI":"10.1101\/cshperspect.a020420","volume":"7","author":"MV Sofroniew","year":"2014","unstructured":"Sofroniew MV. Astrogliosis. Cold Spring Harb Perspect Biol. 2014;7(2):a020420.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"34","key":"3188_CR46","doi-asserted-by":"publisher","first-page":"26252","DOI":"10.1074\/jbc.M002226200","volume":"275","author":"E Vereker","year":"2000","unstructured":"Vereker E, Campbell V, Roche E, McEntee E, Lynch MA. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem. 2000;275(34):26252\u20138.","journal-title":"J Biol Chem"},{"key":"3188_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc1884","author":"PP Ogger","year":"2020","unstructured":"Ogger PP, Albers GJ, Hewitt RJ, O\u2019Sullivan BJ, Powell JE, Calamita E, et al. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020. https:\/\/doi.org\/10.1126\/sciimmunol.abc1884.","journal-title":"Sci Immunol"},{"issue":"4","key":"3188_CR48","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1002\/hep.31147","volume":"72","author":"Z Yi","year":"2020","unstructured":"Yi Z, Deng M, Scott MJ, Fu G, Loughran PA, Lei Z, et al. Immune-responsive gene 1\/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury. Hepatology. 2020;72(4):1394\u2013411.","journal-title":"Hepatology"},{"issue":"3","key":"3188_CR49","first-page":"1155","volume":"13","author":"D Zhu","year":"2021","unstructured":"Zhu D, Zhao Y, Luo Y, Qian X, Zhang Z, Jiang G, et al. Irg1-itaconate axis protects against acute kidney injury via activation of Nrf2. Am J Transl Res. 2021;13(3):1155\u201369.","journal-title":"Am J Transl Res"},{"key":"3188_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23084392","author":"HW Kim","year":"2022","unstructured":"Kim HW, Yu AR, Lee JW, Yoon HS, Lee BS, Park HW, et al. Aconitate decarboxylase 1 deficiency exacerbates mouse colitis induced by dextran sodium sulfate. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23084392.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3188_CR51","doi-asserted-by":"publisher","first-page":"e1010219","DOI":"10.1371\/journal.ppat.1010219","volume":"18","author":"A Sohail","year":"2022","unstructured":"Sohail A, Iqbal AA, Sahini N, Chen F, Tantawy M, Waqas SFH, et al. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog. 2022;18(1):e1010219.","journal-title":"PLoS Pathog"},{"key":"3188_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-023-01278-x","author":"W Yang","year":"2023","unstructured":"Yang W, Wang Y, Huang Y, Wang T, Li C, Zhang P, et al. Immune response gene-1 [IRG1]\/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response. Inflammopharmacology. 2023. https:\/\/doi.org\/10.1007\/s10787-023-01278-x.","journal-title":"Inflammopharmacology"},{"issue":"3","key":"3188_CR53","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/braincomms\/fcab187","volume":"3","author":"PC Kuo","year":"2021","unstructured":"Kuo PC, Weng WT, Scofield BA, Furnas D, Paraiso HC, Yu IC, et al. Immunoresponsive gene 1 modulates the severity of brain injury in cerebral ischaemia. Brain Commun. 2021;3(3):187.","journal-title":"Brain Commun"},{"issue":"12","key":"3188_CR54","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1523\/JNEUROSCI.6389-11.2012","volume":"32","author":"HA Jurgens","year":"2012","unstructured":"Jurgens HA, Amancherla K, Johnson RW. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci. 2012;32(12):3958\u201368.","journal-title":"J Neurosci"},{"issue":"6","key":"3188_CR55","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.mp.4000813","volume":"5","author":"L Vitkovic","year":"2000","unstructured":"Vitkovic L, Konsman JP, Bockaert J, Dantzer R, Homburger V, Jacque C. Cytokine signals propagate through the brain. Mol Psychiatry. 2000;5(6):604\u201315.","journal-title":"Mol Psychiatry"},{"key":"3188_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0083-6729(02)64006-3","volume":"64","author":"MA Lynch","year":"2002","unstructured":"Lynch MA. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Vitam Horm. 2002;64:185\u2013219.","journal-title":"Vitam Horm"},{"issue":"1","key":"3188_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cei\/uxac058","volume":"210","author":"P Nwaubani","year":"2022","unstructured":"Nwaubani P, Cercignani M, Colasanti A. In vivo quantitative imaging of hippocampal inflammation in autoimmune neuroinflammatory conditions: a systematic review. Clin Exp Immunol. 2022;210(1):24\u201338.","journal-title":"Clin Exp Immunol"},{"key":"3188_CR58","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fncel.2017.00216","volume":"11","author":"D Kempuraj","year":"2017","unstructured":"Kempuraj D, Thangavel R, Selvakumar GP, Zaheer S, Ahmed ME, Raikwar SP, et al. Brain and peripheral atypical inflammatory mediators potentiate neuroinflammation and neurodegeneration. Front Cell Neurosci. 2017;11:216.","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"3188_CR59","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O'Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N, et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry. 2009;14(5):511\u201322.","journal-title":"Mol Psychiatry"},{"issue":"4","key":"3188_CR60","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ. Role of neuroinflammation in neurodegenerative diseases (review). Mol Med Rep. 2016;13(4):3391\u20136.","journal-title":"Mol Med Rep"},{"key":"3188_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092293","author":"CRA Batista","year":"2019","unstructured":"Batista CRA, Gomes GF, Candelario-Jalil E, Fiebich BL, de Oliveira ACP. Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20092293.","journal-title":"Int J Mol Sci"},{"issue":"4\u20135","key":"3188_CR62","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S1359-6101(02)00026-6","volume":"13","author":"T Hanada","year":"2002","unstructured":"Hanada T, Yoshimura A. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002;13(4\u20135):413\u201321.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"2","key":"3188_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27\u201337.","journal-title":"Int Anesthesiol Clin"},{"key":"3188_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20236008.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3188_CR65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00702-017-1732-9","volume":"125","author":"AS Mendiola","year":"2018","unstructured":"Mendiola AS, Cardona AE. The IL-1beta phenomena in neuroinflammatory diseases. J Neural Transm. 2018;125(5):781\u201395.","journal-title":"J Neural Transm"},{"issue":"7702","key":"3188_CR66","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41586-018-0052-z","volume":"556","author":"M Bambouskova","year":"2018","unstructured":"Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, et al. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature. 2018;556(7702):501\u20134.","journal-title":"Nature"},{"key":"3188_CR67","doi-asserted-by":"publisher","first-page":"103541","DOI":"10.1016\/j.micpath.2019.05.024","volume":"133","author":"C Zhao","year":"2019","unstructured":"Zhao C, Jiang P, He Z, Yuan X, Guo J, Li Y, et al. Dimethyl itaconate protects against lippolysacchride-induced mastitis in mice by activating MAPKs and Nrf2 and inhibiting NF-\u03baB signaling pathways. Microb Pathog. 2019;133:103541.","journal-title":"Microb Pathog"},{"issue":"5","key":"3188_CR68","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s42255-022-00577-x","volume":"4","author":"F Chen","year":"2022","unstructured":"Chen F, Elgaher WAM, Winterhoff M, Bussow K, Waqas FH, Graner E, et al. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat Metab. 2022;4(5):534\u201346.","journal-title":"Nat Metab"},{"issue":"1","key":"3188_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012;32(1):23\u201363.","journal-title":"Crit Rev Immunol"},{"key":"3188_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115996","author":"ES Wickstead","year":"2023","unstructured":"Wickstead ES, Elliott BT, Pokorny S, Biggs C, Getting SJ, McArthur S. Stimulation of the pro-resolving receptor Fpr2 reverses inflammatory microglial activity by suppressing NF\u03baB activity. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms242115996.","journal-title":"Int J Mol Sci"},{"key":"3188_CR71","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.redox.2023.102863","volume":"66","author":"W Tao","year":"2023","unstructured":"Tao W, Zhang G, Liu C, Jin L, Li X, Yang S. Low-dose LPS alleviates early brain injury after SAH by modulating microglial M1\/M2 polarization via USP19\/FOXO1\/IL-10\/IL-10R1 signaling. Redox Biol. 2023;66:102863.","journal-title":"Redox Biol"},{"issue":"2","key":"3188_CR72","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2016.09.073","volume":"479","author":"M Go","year":"2016","unstructured":"Go M, Kou J, Lim JE, Yang J, Fukuchi KI. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer\u2019s mouse model: implication of TLR4 signaling in disease progression. Biochem Biophys Res Commun. 2016;479(2):331\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3188_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cmet.2022.02.002","volume":"34","author":"MC Runtsch","year":"2022","unstructured":"Runtsch MC, Angiari S, Hooftman A, Wadhwa R, Zhang Y, Zheng Y, et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 2022;34(3):487\u2013501.","journal-title":"Cell Metab"},{"issue":"4","key":"3188_CR74","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10753-023-01819-0","volume":"46","author":"Z Li","year":"2023","unstructured":"Li Z, Zheng W, Kong W, Zeng T. Itaconate: a potent macrophage immunomodulator. Inflammation. 2023;46(4):1177\u201391.","journal-title":"Inflammation"},{"issue":"21","key":"3188_CR75","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli RC, Sierra A, Stevens B, Tremblay ME, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110(21):3458\u201383.","journal-title":"Neuron"},{"key":"3188_CR76","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fncel.2020.00198","volume":"14","author":"AM Jurga","year":"2020","unstructured":"Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"3188_CR77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s40478-023-01561-6","volume":"11","author":"MEV Swanson","year":"2023","unstructured":"Swanson MEV, Mrkela M, Murray HC, Cao MC, Turner C, Curtis MA, et al. Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain. Acta Neuropathol Commun. 2023;11(1):69.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"3188_CR78","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42826-019-0018-9","volume":"35","author":"JB Kang","year":"2019","unstructured":"Kang JB, Park DJ, Shah MA, Kim MO, Koh PO. Lipopolysaccharide induces neuroglia activation and NF-kappaB activation in cerebral cortex of adult mice. Lab Anim Res. 2019;35(1):19.","journal-title":"Lab Anim Res"},{"issue":"2","key":"3188_CR79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0306-4522(00)00498-X","volume":"102","author":"S Commins","year":"2001","unstructured":"Commins S, O\u2019Neill LA, O\u2019Mara SM. The effects of the bacterial endotoxin lipopolysaccharide on synaptic transmission and plasticity in the CA1-subiculum pathway in vivo. Neuroscience. 2001;102(2):273\u201380.","journal-title":"Neuroscience"},{"issue":"1","key":"3188_CR80","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.brainres.2006.10.066","volume":"1130","author":"A Hennigan","year":"2007","unstructured":"Hennigan A, Trotter C, Kelly AM. Lipopolysaccharide impairs long-term potentiation and recognition memory and increases p75NTR expression in the rat dentate gyrus. Brain Res. 2007;1130(1):158\u201366.","journal-title":"Brain Res"},{"issue":"8","key":"3188_CR81","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.tips.2008.06.005","volume":"29","author":"M Di Filippo","year":"2008","unstructured":"Di Filippo M, Sarchielli P, Picconi B, Calabresi P. Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci. 2008;29(8):402\u201312.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"3188_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000179661","volume":"16","author":"I Camacho-Arroyo","year":"2009","unstructured":"Camacho-Arroyo I, Lopez-Griego L, Morales-Montor J. The role of cytokines in the regulation of neurotransmission. NeuroImmunoModulation. 2009;16(1):1\u201312.","journal-title":"NeuroImmunoModulation"},{"issue":"1","key":"3188_CR83","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1152\/physrev.00039.2016","volume":"98","author":"R Dantzer","year":"2018","unstructured":"Dantzer R. Neuroimmune interactions: from the brain to the immune system and vice versa. Physiol Rev. 2018;98(1):477\u2013504.","journal-title":"Physiol Rev"},{"issue":"7","key":"3188_CR84","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/hipo.10135","volume":"13","author":"A Avital","year":"2003","unstructured":"Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, et al. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus. 2003;13(7):826\u201334.","journal-title":"Hippocampus"},{"issue":"21","key":"3188_CR85","doi-asserted-by":"publisher","first-page":"19453","DOI":"10.1074\/jbc.M301938200","volume":"278","author":"A Kelly","year":"2003","unstructured":"Kelly A, Vereker E, Nolan Y, Brady M, Barry C, Loscher CE, et al. Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem. 2003;278(21):19453\u201362.","journal-title":"J Biol Chem"},{"issue":"1","key":"3188_CR86","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1471-4159.2004.03011.x","volume":"93","author":"CE Barry","year":"2005","unstructured":"Barry CE, Nolan Y, Clarke RM, Lynch A, Lynch MA. Activation of c-Jun-N-terminal kinase is critical in mediating lipopolysaccharide-induced changes in the rat hippocampus. J Neurochem. 2005;93(1):221\u201331.","journal-title":"J Neurochem"},{"issue":"9\u201310","key":"3188_CR87","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1097\/00001756-199707070-00004","volume":"8","author":"A Coogan","year":"1997","unstructured":"Coogan A, O\u2019Connor JJ. Inhibition of NMDA receptor-mediated synaptic transmission in the rat dentate gyrus in vitro by IL-1 beta. NeuroReport. 1997;8(9\u201310):2107\u201310.","journal-title":"NeuroReport"},{"issue":"1\u20132","key":"3188_CR88","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jneuroim.2006.03.001","volume":"175","author":"AY Lai","year":"2006","unstructured":"Lai AY, Swayze RD, El-Husseini A, Song C. Interleukin-1 beta modulates AMPA receptor expression and phosphorylation in hippocampal neurons. J Neuroimmunol. 2006;175(1\u20132):97\u2013106.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"3188_CR89","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.immuni.2018.11.017","volume":"50","author":"BP Daniels","year":"2019","unstructured":"Daniels BP, Kofman SB, Smith JR, Norris GT, Snyder AG, Kolb JP, et al. The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity. 2019;50(1):64\u201376.","journal-title":"Immunity"},{"issue":"17","key":"3188_CR90","doi-asserted-by":"publisher","first-page":"0654","DOI":"10.1126\/sciadv.adg0654","volume":"9","author":"YJ Chen","year":"2023","unstructured":"Chen YJ, Li GN, Li XJ, Wei LX, Fu MJ, Cheng ZL, et al. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Sci Adv. 2023;9(17):0654.","journal-title":"Sci Adv"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03188-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03188-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T14:05:56Z","timestamp":1724162756000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03188-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3188"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03188-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4521895\/v1","asserted-by":"object"}]},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by the animal welfare representative of the TU Braunschweig and the LAVES (Oldenburg, Germany, Az. \u00a74 (02.05) TSchB TU BS and Az. 33.19\u201342502-04- 21\u20133734).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}